| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 5,453,000 | 5,497,000 | 5,371,000 | 7,136,000 | | Cost of Revenue | 3,645,000 | 3,787,000 | 3,875,000 | 5,014,000 | | | Gross Profit | 1,808,000 | 1,710,000 | 1,496,000 | 2,122,000 | | | Operating Expenses | | Research Development | 768,000 | 775,000 | 847,000 | 1,008,000 | | Selling General and Administrative | 912,000 | 1,154,000 | 869,000 | 988,000 | | Non Recurring |
-
| (229,000) | 229,000 | 2,045,000 | | Others |
-
|
-
|
-
| (244,000) | | | | Total Operating Expenses |
-
|
-
|
-
| 3,797,000 | | | | Operating Income or Loss | 128,000 | 10,000 | (449,000) | (1,675,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (43,000) | 26,000 | 77,000 | (30,000) | | Earnings Before Interest And Taxes | (29,000) | 36,000 | (372,000) | (1,705,000) | | Interest Expense | (65,000) | 3,000 | 62,000 | 20,000 | | Income Before Tax | 36,000 | 33,000 | (434,000) | (1,725,000) | | Income Tax Expense | 14,000 | (2,000) | (146,000) | 1,932,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,000 | 35,000 | (288,000) | (3,657,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 60,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income |
-
| 35,000 | (228,000) | (3,657,000) | | Preferred Stock And Other Adjustments | 12,000 | (9,000) | (3,000) |
-
| | | Net Income Applicable To Common Shares | $12,000 | $26,000 | ($231,000) | ($3,657,000) |
|
0.51% Nasdaq 
Income Statement
